IRIS Accounts Production v23.3.1.45 13416130 director 1.6.22 31.5.23 31.5.23 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure134161302022-05-31134161302023-05-31134161302022-06-012023-05-31134161302021-05-22134161302021-05-232022-05-31134161302022-05-3113416130ns16:EnglandWales2022-06-012023-05-3113416130ns15:PoundSterling2022-06-012023-05-3113416130ns11:Director12022-06-012023-05-3113416130ns11:PrivateLimitedCompanyLtd2022-06-012023-05-3113416130ns11:SmallEntities2022-06-012023-05-3113416130ns11:AuditExemptWithAccountantsReport2022-06-012023-05-3113416130ns11:SmallCompaniesRegimeForDirectorsReport2022-06-012023-05-3113416130ns11:SmallCompaniesRegimeForAccounts2022-06-012023-05-3113416130ns11:FullAccounts2022-06-012023-05-3113416130ns11:CompanySecretary12022-06-012023-05-3113416130ns11:RegisteredOffice2022-06-012023-05-3113416130ns6:CurrentFinancialInstruments2023-05-3113416130ns6:CurrentFinancialInstruments2022-05-3113416130ns6:Non-currentFinancialInstruments2023-05-3113416130ns6:Non-currentFinancialInstruments2022-05-3113416130ns6:ShareCapital2023-05-3113416130ns6:ShareCapital2022-05-3113416130ns6:RetainedEarningsAccumulatedLosses2023-05-3113416130ns6:RetainedEarningsAccumulatedLosses2022-05-3113416130ns6:OwnedAssets2022-06-012023-05-3113416130ns6:OwnedAssets2021-05-232022-05-3113416130ns6:FurnitureFittings2022-05-3113416130ns6:MotorVehicles2022-05-3113416130ns6:ComputerEquipment2022-05-3113416130ns6:FurnitureFittings2022-06-012023-05-3113416130ns6:MotorVehicles2022-06-012023-05-3113416130ns6:ComputerEquipment2022-06-012023-05-3113416130ns6:FurnitureFittings2023-05-3113416130ns6:MotorVehicles2023-05-3113416130ns6:ComputerEquipment2023-05-3113416130ns6:FurnitureFittings2022-05-3113416130ns6:MotorVehicles2022-05-3113416130ns6:ComputerEquipment2022-05-3113416130ns6:WithinOneYearns6:CurrentFinancialInstruments2023-05-3113416130ns6:WithinOneYearns6:CurrentFinancialInstruments2022-05-31
REGISTERED NUMBER: 13416130 (England and Wales)















Report of the Director and

Financial Statements for the Year Ended 31 May 2023

for

MARMADUKE MEDICAL LIMITED

MARMADUKE MEDICAL LIMITED (Registered number: 13416130)






Contents of the Financial Statements
for the Year Ended 31 May 2023




Page

Company Information 1

Report of the Director 2

Income Statement 3

Balance Sheet 4

Notes to the Financial Statements 5


MARMADUKE MEDICAL LIMITED

Company Information
for the Year Ended 31 May 2023







DIRECTOR: DR S HASAN





SECRETARY:





REGISTERED OFFICE: 16 SPENCER WALK
LONDON
SW15 1PL





REGISTERED NUMBER: 13416130 (England and Wales)





ACCOUNTANTS: B MEHTA & CO
102
STREATFIELD ROAD
HARROW
Middlesex
HA3 9BT

MARMADUKE MEDICAL LIMITED (Registered number: 13416130)

Report of the Director
for the Year Ended 31 May 2023

The director presents her report with the financial statements of the company for the year ended 31 May 2023.

PRINCIPAL ACTIVITY
The principal activity of the company in the year under review was that of Medical Consultancy Services

DIRECTOR
DR S HASAN held office during the whole of the period from 1 June 2022 to the date of this report.

This report has been prepared in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

ON BEHALF OF THE BOARD:





DR S HASAN - Director


12 January 2024

MARMADUKE MEDICAL LIMITED (Registered number: 13416130)

Income Statement
for the Year Ended 31 May 2023

Year Ended Period
31.5.23 23.5.21 to 31.5.22
Notes £    £    £    £   

TURNOVER 279,044 225,068

Cost of sales 52,054 41,892
GROSS PROFIT 226,990 183,176

Distribution costs 41,200 36,800
Administrative expenses 149,310 96,311
190,510 133,111
OPERATING PROFIT and
PROFIT BEFORE TAXATION 36,480 50,065

Tax on profit 6,480 8,668
PROFIT FOR THE FINANCIAL YEAR 30,000 41,397

MARMADUKE MEDICAL LIMITED (Registered number: 13416130)

Balance Sheet
31 May 2023

31.5.23 31.5.22
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 5 47,278 53,787

CURRENT ASSETS
Debtors 6 - 7,537
Cash at bank 174,651 137,044
174,651 144,581
CREDITORS
Amounts falling due within one year 7 143,270 133,660
NET CURRENT ASSETS 31,381 10,921
TOTAL ASSETS LESS CURRENT
LIABILITIES

78,659

64,708

CREDITORS
Amounts falling due after more than one
year

8

7,162

23,211
NET ASSETS 71,497 41,497

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 71,397 41,397
71,497 41,497

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 May 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 May 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the director and authorised for issue on 12 January 2024 and were signed by:




DR S HASAN - Director


MARMADUKE MEDICAL LIMITED (Registered number: 13416130)

Notes to the Financial Statements
for the Year Ended 31 May 2023

1. STATUTORY INFORMATION

MARMADUKE MEDICAL LIMITED is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2022 - 1 ) .

MARMADUKE MEDICAL LIMITED (Registered number: 13416130)

Notes to the Financial Statements - continued
for the Year Ended 31 May 2023

4. OPERATING PROFIT

The operating profit is stated after charging:

Period
23.5.21
Year Ended to
31.5.23 31.5.22
£    £   
Depreciation - owned assets 6,509 6,389

5. TANGIBLE FIXED ASSETS
Fixtures
and Motor Computer
fittings vehicles equipment Totals
£    £    £    £   
COST
At 1 June 2022
and 31 May 2023 21,116 35,500 3,560 60,176
DEPRECIATION
At 1 June 2022 2,909 2,840 640 6,389
Charge for year 3,370 2,613 526 6,509
At 31 May 2023 6,279 5,453 1,166 12,898
NET BOOK VALUE
At 31 May 2023 14,837 30,047 2,394 47,278
At 31 May 2022 18,207 32,660 2,920 53,787

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.5.23 31.5.22
£    £   
Other debtors - 7,537

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.5.23 31.5.22
£    £   
Taxation and social security 22,256 30,273
Other creditors 121,014 103,387
143,270 133,660

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
31.5.23 31.5.22
£    £   
Hire purchase contracts 7,162 23,211

MARMADUKE MEDICAL LIMITED (Registered number: 13416130)

Notes to the Financial Statements - continued
for the Year Ended 31 May 2023

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR - continued
31.5.23 31.5.22
£    £   
Amounts falling due in more than five years:

Repayable by instalments
Hire purchase 7,162 15,318